LPL Financial’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Buy
120,796
+22,255
+23% +$39.5K ﹤0.01% 5481
2025
Q4
$140K Sell
98,541
-120,600
-55% -$176K ﹤0.01% 5541
2025
Q3
$359K Buy
219,141
+17,302
+9% +$19.2K ﹤0.01% 4900
2025
Q2
$148K Buy
201,839
+135,620
+205% +$117K ﹤0.01% 5178
2025
Q1
$53.4K Buy
66,219
+1,454
+2% +$1.67K ﹤0.01% 5148
2024
Q4
$89.4K Sell
64,765
-29,321
-31% -$32.9K ﹤0.01% 5013
2024
Q3
$97.8K Sell
94,086
-24,400
-21% -$33.5K ﹤0.01% 4895
2024
Q2
$205K Buy
118,486
+5,750
+5% +$11.6K ﹤0.01% 4552
2024
Q1
$269K Buy
112,736
+57,702
+105% +$142K ﹤0.01% 4289
2023
Q4
$183K Buy
+55,034
New +$147K ﹤0.01% 4415

Other funds holding CHRS